Fingerprint
Dive into the research topics of 'Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically